Novo Nordisk and Alvotech Face Continued FDA Scrutiny at Plants Tied to Recent FDA Rejections on July 17, 2026 Alvotech Biosimilars Bloomington Indiana Cautionary Warning Letter [Publication Type] Ozempic Plainsboro New Jersey Qualitative form Reykjavik plant scrutiny United States Food and Drug Administration +